Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.52 |
| ▸ | KDM5C | P41229 | 2/20 | 0.52 |
| ▸ | PHF8 | Q9UPP1 | 2/20 | 0.52 |
| ▸ | KDM2A | Q9Y2K7 | 2/20 | 0.52 |
| ▸ | CTSD | P07339 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.37 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.36 |
| ▸ | POLB | P06746 | 1/20 | 0.33 |
| ▸ | HTT | P42858 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.33 |
| ▸ | GAA | P10253 | 2/20 | 0.32 |
| ▸ | GRIK1 | P39086 | 1/20 | 0.31 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.31 |
| ▸ | EGLN1 | Q9GZT9 | 1/20 | 0.30 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1662968 | 0.92 | ALDH1A1 (0.47) | KDM4EKDM5CPHF8KDM2ACTSD | |
| SCHEMBL1661782 | 0.92 | KDM4E (0.43) | KDM4EKDM5CPHF8KDM2ACTSD | |
| SCHEMBL1662970 | 0.90 | CTSD (0.63) | KDM4EKDM5CPHF8KDM2ACTSD | |
| SCHEMBL1660833 | 0.90 | ALDH1A1 (0.50) | KDM4EKDM5CPHF8KDM2ACTSD | |
| SCHEMBL1660553 | 0.90 | ALDH1A1 (0.50) | KDM4EKDM5CPHF8KDM2ACTSD | |
| SCHEMBL1660839 | 0.89 | KDM4E (0.38) | KDM4EKDM5CPHF8KDM2ACTSD | |
| SCHEMBL1661048 | 0.87 | CTSD (0.48) | KDM4EKDM5CPHF8KDM2ACTSD | |
| SCHEMBL1661038 | 0.86 | CTSD (0.40) | KDM4EKDM5CPHF8KDM2ACTSD | |
| SCHEMBL1661786 | 0.86 | FAAH (0.47) | CTSDALDH1A1CYP1A2CYP3A4CYP2C19 | |
| Tetradecanehydrazide SCHEMBL1661791 | 0.84 | FAAH (0.50) | CTSDALDH1A1CYP1A2CYP3A4CYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110086761-A1 | COMPOSITIONS AND METHODS TO CONTROL OOMYCETE FUNGAL PATHOGENS | DOW AGROSCIENCES LLC (US) | 2011-04-14 | — | — | US | claimed |
| US-20110086761-A1 | COMPOSITIONS AND METHODS TO CONTROL OOMYCETE FUNGAL PATHOGENS | DOW AGROSCIENCES LLC (US) | 2011-04-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110086761-A1 | COMPOSITIONS AND METHODS TO CONTROL OOMYCETE FUNGAL PATHOGENS | ERG28, DPM1, BROX | KDM4E 1284/4885KDM5C 127/4885PHF8 444/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.